5AM Ventures VI, L.P. → CAMP4 THERAPEUTICS CORPORATION CAMP

Stake: 9.90% Shares: 2,625,145 CUSIP: 13463J101 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 5.13

1,459,951 shares short · +47.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-31	Gold Kelly	officer	Buy	10,000	$3.96	$40K

Other 13D/G Filings on CAMP4 THERAPEUTICS CORPORATION

Filed	Form	Filer	Stake	Shares
2026-08-31	SCHEDULE 13D/A	5AM Ventures VI, L.P.	9.90%	2,033,270	view →
2026-08-19	SCHEDULE 13D/A	Polaris Management Co. VII, L.L.C.	6.30%	3,023,161	view →
2025-09-15	SCHEDULE	Enavate Sciences GP, LLC	8.10%	3,785,802	view →

Other Filings by 5AM Ventures VI, L.P.

Filed	Form	Issuer	Stake	Shares
2026-08-31	SCHEDULE 13D/A	CAMP4 THERAPEUTICS CORPORATION	9.90%	2,033,270	view →
2023-08-28	SC	Enliven Therapeutics, Inc. ELVN	—	—	view →
2023-02-28	SC	CinCor Pharma, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →